Access and use of quinacrine (mepacrine) in the treatment of resistant giardiasis
Infect Dis Now
.
2021 Nov;51(8):682-684.
doi: 10.1016/j.idnow.2021.03.006.
Epub 2021 Mar 24.
Authors
Clemence Delaye
1
,
Felipe Suarez
2
,
Claire Aguilar
3
,
Corinne Guerin
1
,
Rui Batista
1
,
Celine Chasport
4
,
Andre Paugam
5
,
Jeremie Zerbit
6
Affiliations
1
Pharmacy Department, Cochin Hospital, AP-HP, Paris, France.
2
Department of Hematology, Necker Hospital, AP-HP, Paris, France.
3
Division of Infectious Diseases and Tropical Medicine, Necker Hospital, AP-HP, Paris, France.
4
Pharmacy Department, Necker Hospital, AP-HP, Paris, France.
5
Parasitology-Mycology Laboratory, Université de Paris, Cochin Hospital, AP-HP, Paris, France.
6
Pharmacy Department, Cochin Hospital, AP-HP, Paris, France. Electronic address:
[email protected]
.
PMID:
33774205
DOI:
10.1016/j.idnow.2021.03.006
No abstract available
Keywords:
Giardiasis; Mepacrine; Quinacrine.
Publication types
Letter
MeSH terms
Giardiasis* / drug therapy
Humans
Quinacrine / therapeutic use
Substances
Quinacrine